Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Study to Analyze the Osteogenic Action of a Beta-tricalcium Phosphate-based Product in Bone Regeneration After the Extraction of Impacted Mandibular Third Molars.

NCT06935747 is registered in ClinicalTrials.gov with Mario Pérez Sayáns as lead sponsor.

NCT NCT06935747
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06935747 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Study to Analyze the Osteogenic Action of a Beta-tricalcium Phosphate-based Product in Bone Regeneration After the Extraction of Impacted Mandibular Third Molars.
Lead sponsor
Mario Pérez Sayáns
Phase
Phase 4
Overall status
Not yet recruiting
Start date
July 31, 2025
Completion date
July 31, 2026
Enrollment
30 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

bone loss, regenerative inflammation, third molars extraction